Stock Information

• Abeona Therapeutics Highlights ZEVASKYN Launch Momentum, Revenue Growth at H.C. Wainwright
  Tue, Sep 22, 2026 10:02 PM
• Abeona Expands ZEVASKYN Network as RDEB Launch Gains Momentum
  Tue, Sep 22, 2026 8:02 AM
• Abeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)
  Fri, Sep 18, 2026 11:30 AM
• Apple To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Friday
  Fri, Sep 18, 2026 8:31 AM
• Abeona Stands to Collect Royalties After Ultragenyx's FDA Approval — Here's the Rest of the Week
  Fri, Sep 18, 2026 7:51 AM
• Cantor Fitzgerald Maintains Overweight on Abeona Therapeutics, Raises Price Target to $30
  Fri, Sep 18, 2026 5:45 AM
• ABEO Stock Gains On Approval For A Drug Abeona Sold, Rating For The One It Sells
  Thu, Sep 17, 2026 11:33 PM
• Ultragenyx Pharmaceutical Says FDA Grants Standard Full Approval Of FAYUVI For Treatment Of Pediatric Patients With Mucopolysaccharidosis Type IIIA
  Thu, Sep 17, 2026 3:54 PM
• Roth Capital Initiates Coverage On Abeona Therapeutics with Buy Rating, Announces Price Target of $17
  Thu, Sep 17, 2026 6:09 AM

Financial data not available